Acute 0 5 0 5 B-chronic_disease
sinusitis 6 15 6 15 I-chronic_disease
within 16 22 16 22 O
the 23 26 23 26 O
last 27 31 27 31 B-upper_bound
six 32 35 32 35 I-upper_bound
weeks 36 41 36 41 I-upper_bound
prior 42 47 42 47 I-upper_bound
to 48 50 48 50 O
enrollment 51 61 51 61 O

Any 0 3 62 65 O
concurrent 4 14 66 76 B-treatment
medication 15 25 77 87 I-treatment
or 26 28 88 90 O
any 29 32 91 94 O
medication 33 43 95 105 O
within 44 50 106 112 O
2 51 52 113 114 B-upper_bound
weeks 53 58 115 120 I-upper_bound
preceding 59 68 121 130 I-upper_bound
the 69 72 131 134 O
start 73 78 135 140 O
of 79 81 141 143 O
the 82 85 144 147 O
study 86 91 148 153 O

Any 0 3 154 157 O
history 4 11 158 165 O
and/or 12 18 166 172 O
conditions 19 29 173 183 O
that 30 34 184 188 O
might 35 40 189 194 O
interfere 41 50 195 204 O
with 51 55 205 209 O
drug 56 60 210 214 O
absorption 61 71 215 225 O
, 71 72 225 226 O
distribution 73 85 227 239 O
, 85 86 239 240 O
metabolism 87 97 241 251 O
or 98 100 252 254 O
excretion 101 110 255 264 O
of 111 113 265 267 O
MF 114 116 268 270 O
, 116 117 270 271 O
e.g. 118 122 272 276 O
, 122 123 276 277 O
preexisting 124 135 278 289 O
lung 136 140 290 294 B-chronic_disease
and 141 144 295 298 O
liver 145 150 299 304 B-chronic_disease
disease 151 158 305 312 I-chronic_disease

Any 0 3 313 316 O
history 4 11 317 324 O
of 12 14 325 327 O
nasal 15 20 328 333 B-treatment
surgery 21 28 334 341 I-treatment
or 29 31 342 344 O
known 32 37 345 350 O
clinically 38 48 351 361 O
relevant 49 57 362 370 O
abnormalities 58 71 371 384 O
, 71 72 384 385 O
such 73 77 386 390 O
as 78 80 391 393 O
rhinitis 81 89 394 402 B-chronic_disease
medicamentosa 90 103 403 416 I-chronic_disease
, 103 104 416 417 O
polyposis 105 114 418 427 B-chronic_disease
, 114 115 427 428 O
septum 116 122 429 435 B-chronic_disease
deviation 123 132 436 445 I-chronic_disease
with 133 137 446 450 O
clinical 138 146 451 459 O
symptoms 147 155 460 468 O
, 155 156 468 469 O
recent 157 163 470 476 O
nasal 164 169 477 482 B-chronic_disease
trauma 170 176 483 489 I-chronic_disease
, 176 177 489 490 O
or 178 180 491 493 O
nasal 181 186 494 499 O
structural 187 197 500 510 O
abnormalities 198 211 511 524 O

Atrophic 0 8 525 533 B-chronic_disease
rhinitis 9 17 534 542 I-chronic_disease
or 18 20 543 545 O
rhinitis 21 29 546 554 B-chronic_disease
medicamentosa 30 43 555 568 I-chronic_disease
within 44 50 569 575 O
the 51 54 576 579 O
last 55 59 580 584 B-upper_bound
60 60 62 585 587 I-upper_bound
days 63 67 588 592 I-upper_bound

Body 0 4 593 597 B-bmi
mass 5 9 598 602 I-bmi
index 10 15 603 608 I-bmi
( 16 17 609 610 I-bmi
BMI 17 20 610 613 I-bmi
) 20 21 613 614 I-bmi
between 22 29 615 622 O
18.5 30 34 623 627 B-lower_bound
and 35 38 628 631 O
30.0 39 43 632 636 B-upper_bound
kg 44 46 637 639 I-upper_bound
/ 46 47 639 640 I-upper_bound
m2 47 49 640 642 I-upper_bound

Current 0 7 643 650 O
use 8 11 651 654 O
of 12 14 655 657 O
hormone 15 22 658 665 B-treatment
replacement 23 34 666 677 I-treatment
therapy 35 42 678 685 I-treatment
( 43 44 686 687 I-treatment
HRT 44 47 687 690 I-treatment
) 47 48 690 691 I-treatment
, 48 49 691 692 O
hormonal 50 58 693 701 B-contraception_consent
contraceptives 59 73 702 716 I-contraception_consent
( 74 75 717 718 O
oral 75 79 718 722 B-contraception_consent
, 79 80 722 723 O
implants 81 89 724 732 B-contraception_consent
, 89 90 732 733 O
or 91 93 734 736 O
IUDs 94 98 737 741 B-contraception_consent
) 98 99 741 742 O
and/or 100 106 743 749 O
use 107 110 750 753 O
corticosteroid 111 125 754 768 B-treatment
within 126 132 769 775 O
the 133 136 776 779 O
last 137 141 780 784 B-upper_bound
2 142 143 785 786 I-upper_bound
month 144 149 787 792 I-upper_bound

Exposure 0 8 793 801 O
to 9 11 802 804 O
any 12 15 805 808 O
investigational 16 31 809 824 B-treatment
drug 32 36 825 829 I-treatment
within 37 43 830 836 O
30 44 46 837 839 B-upper_bound
days 47 51 840 844 I-upper_bound
of 52 54 845 847 O
enrollment 55 65 848 858 O

Exposure 0 8 859 867 O
to 9 11 868 870 O
any 12 15 871 874 O
medication 16 26 875 885 O
/ 26 27 885 886 O
food 27 31 886 890 O
that 32 36 891 895 O
alters 37 43 896 902 O
the 44 47 903 906 O
CYP 48 51 907 910 O
3A4 52 55 911 914 O
activity 56 64 915 923 O
within 65 71 924 930 O
last 72 76 931 935 B-upper_bound
2 77 78 936 937 I-upper_bound
weeks 79 84 938 943 I-upper_bound
( 85 86 944 945 O
e.g. 86 90 945 949 O
any 91 94 950 953 O
grapefruit 95 105 954 964 B-treatment
products 106 114 965 973 I-treatment
, 114 115 973 974 O
azole 116 121 975 980 B-treatment
anti 122 126 981 985 I-treatment
- 126 127 985 986 I-treatment
fungals 127 134 986 993 I-treatment
, 134 135 993 994 O
or 136 138 995 997 O
rifampin 139 147 998 1006 B-treatment
) 147 148 1006 1007 O

Having 0 6 1008 1014 O
a 7 8 1015 1016 O
history 9 16 1017 1024 O
and/or 17 23 1025 1031 O
currently 24 33 1032 1041 O
having 34 40 1042 1048 O
the 41 44 1049 1052 O
medical 45 52 1053 1060 B-chronic_disease
condition 53 62 1061 1070 I-chronic_disease
in 63 65 1071 1073 O
the 66 69 1074 1077 O
opinion 70 77 1078 1085 O
of 78 80 1086 1088 O
medically 81 90 1089 1098 O
accountable 91 102 1099 1110 O
investigator 103 115 1111 1123 O
and 116 119 1124 1127 O
hence 120 125 1128 1133 O
taking 126 132 1134 1140 O
any 133 136 1141 1144 O
medication 137 147 1145 1155 B-treatment

Healthy 0 7 1156 1163 O
male 8 12 1164 1168 B-gender
or 13 15 1169 1171 O
female 16 22 1172 1178 B-gender

History 0 7 1179 1186 O
of 8 10 1187 1189 O
chronic 11 18 1190 1197 B-chronic_disease
sinus 19 24 1198 1203 I-chronic_disease
disease 25 32 1204 1211 I-chronic_disease
or 33 35 1212 1214 O
sinusitis 36 45 1215 1224 B-chronic_disease
within 46 52 1225 1231 O
the 53 56 1232 1235 O
last 57 61 1236 1240 B-upper_bound
year 62 66 1241 1245 I-upper_bound
prior 67 72 1246 1251 I-upper_bound
to 73 75 1252 1254 O
the 76 79 1255 1258 O
start 80 85 1259 1264 O
of 86 88 1265 1267 O
study 89 94 1268 1273 O

History 0 7 1274 1281 O
of 8 10 1282 1284 O
malignancy 11 21 1285 1295 B-cancer
within 22 28 1296 1302 O
the 29 32 1303 1306 O
past 33 37 1307 1311 B-upper_bound
five 38 42 1312 1316 I-upper_bound
years 43 48 1317 1322 I-upper_bound

History 0 7 1323 1330 O
of 8 10 1331 1333 O
recurrent 11 20 1334 1343 O
epistaxis 21 30 1344 1353 B-chronic_disease
, 30 31 1353 1354 O
or 32 34 1355 1357 O
any 35 38 1358 1361 O
epistaxis 39 48 1362 1371 O
requiring 49 58 1372 1381 O
medical 59 66 1382 1389 O
intervention 67 79 1390 1402 O

Known 0 5 1403 1408 O
or 6 8 1409 1411 O
suspected 9 18 1412 1421 O
sensitivity 19 30 1422 1433 O
or 31 33 1434 1436 O
allergic 34 42 1437 1445 O
reaction 43 51 1446 1454 O
to 52 54 1455 1457 O
MF 55 57 1458 1460 B-allergy_name
, 57 58 1460 1461 O
or 59 61 1462 1464 O
related 62 69 1465 1472 O
compounds 70 79 1473 1482 B-allergy_name
in 80 82 1483 1485 I-allergy_name
that 83 87 1486 1490 I-allergy_name
class 88 93 1491 1496 I-allergy_name
, 93 94 1496 1497 O
or 95 97 1498 1500 O
one 98 101 1501 1504 B-treatment
of 102 104 1505 1507 I-treatment
the 105 108 1508 1511 I-treatment
excipients 109 119 1512 1522 I-treatment
, 119 120 1522 1523 O
or 121 123 1524 1526 O
to 124 126 1527 1529 O
activated 127 136 1530 1539 B-allergy_name
charcoal 137 145 1540 1548 I-allergy_name

Known 0 5 1549 1554 O
or 6 8 1555 1557 O
suspected 9 18 1558 1567 O
sensitivity 19 30 1568 1579 O
to 31 33 1580 1582 O
benzalkonium 34 46 1583 1595 B-allergy_name
chloride 47 55 1596 1604 I-allergy_name
or 56 58 1605 1607 O
to 59 61 1608 1610 O
products 62 70 1611 1619 O
containing 71 81 1620 1630 O
this 82 86 1631 1635 O
salt 87 91 1636 1640 O

Known 0 5 1641 1646 O
perennial 6 15 1647 1656 B-allergy_name
airway 16 22 1657 1663 I-allergy_name
allergies 23 32 1664 1673 I-allergy_name
or 33 35 1674 1676 O
vasomotor 36 45 1677 1686 B-allergy_name
rhinitis 46 54 1687 1695 I-allergy_name

Known 0 5 1696 1701 O
seasonal 6 14 1702 1710 O
airway 15 21 1711 1717 O
allergies 22 31 1718 1727 O
within 32 38 1728 1734 O
the 39 42 1735 1738 O
last 43 47 1739 1743 B-upper_bound
six 48 51 1744 1747 I-upper_bound
weeks 52 57 1748 1753 I-upper_bound
prior 58 63 1754 1759 I-upper_bound
to 64 66 1760 1762 O
the 67 70 1763 1766 O
start 71 76 1767 1772 O
of 77 79 1773 1775 O
the 80 83 1776 1779 O
study 84 89 1780 1785 O
or 90 92 1786 1788 O
seasonal 93 101 1789 1797 O
airway 102 108 1798 1804 O
allergies 109 118 1805 1814 O
that 119 123 1815 1819 O
likely 124 130 1820 1826 O
become 131 137 1827 1833 O
acute 138 143 1834 1839 O
during 144 150 1840 1846 O
the 151 154 1847 1850 O
study 155 160 1851 1856 O
period 161 167 1857 1863 O

No 0 2 1864 1866 O
history 3 10 1867 1874 O
of 11 13 1875 1877 O
major 14 19 1878 1883 O
respiratory 20 31 1884 1895 B-chronic_disease
disease 32 39 1896 1903 I-chronic_disease
( 40 41 1904 1905 O
such 41 45 1905 1909 O
as 46 48 1910 1912 O
cystic 49 55 1913 1919 B-chronic_disease
fibrosis 56 64 1920 1928 I-chronic_disease
or 65 67 1929 1931 O
COPD 68 72 1932 1936 B-chronic_disease
) 72 73 1936 1937 O

Non 0 3 1938 1941 O
- 3 4 1941 1942 O
smoker 4 10 1942 1948 O
for 11 14 1949 1952 O
at 15 17 1953 1955 O
least 18 23 1956 1961 O
12 24 26 1962 1964 B-lower_bound
months 27 33 1965 1971 I-lower_bound
prior 34 39 1972 1977 I-lower_bound
to 40 42 1978 1980 O
study 43 48 1981 1986 O
screening 49 58 1987 1996 O

Presence 0 8 1997 2005 O
of 9 11 2006 2008 O
glaucoma 12 20 2009 2017 B-chronic_disease
, 20 21 2017 2018 O
cataracts 22 31 2019 2028 B-chronic_disease
, 31 32 2028 2029 O
ocular 33 39 2030 2036 B-chronic_disease
herpes 40 46 2037 2043 I-chronic_disease
simplex 47 54 2044 2051 I-chronic_disease
or 55 57 2052 2054 O
carcinoma 58 67 2055 2064 B-cancer
( 68 69 2065 2066 O
other 69 74 2066 2071 O
than 75 79 2072 2076 O
basal 80 85 2077 2082 B-cancer
cell 86 90 2083 2087 I-cancer
) 90 91 2087 2088 O

Presence 0 8 2089 2097 O
of 9 11 2098 2100 O
tuberculosis 12 24 2101 2113 B-chronic_disease
and 25 28 2114 2117 O
other 29 34 2118 2123 O
respiratory 35 46 2124 2135 B-chronic_disease
diseases 47 55 2136 2144 I-chronic_disease

Significant 0 11 2145 2156 O
cardiac 12 19 2157 2164 B-chronic_disease
, 19 20 2164 2165 O
dermatologic 21 33 2166 2178 B-chronic_disease
, 33 34 2178 2179 O
gastrointestinal 35 51 2180 2196 B-chronic_disease
, 51 52 2196 2197 O
hepatic 53 60 2198 2205 B-chronic_disease
, 60 61 2205 2206 O
renal 62 67 2207 2212 B-chronic_disease
, 67 68 2212 2213 O
hematological 69 82 2214 2227 B-chronic_disease
, 82 83 2227 2228 O
neurological 84 96 2229 2241 B-chronic_disease
and 97 100 2242 2245 O
psychiatric 101 112 2246 2257 B-chronic_disease
disease 113 120 2258 2265 I-chronic_disease
( 121 122 2266 2267 O
determined 122 132 2267 2277 O
by 133 135 2278 2280 O
physical 136 144 2281 2289 O
exam 145 149 2290 2294 O
, 149 150 2294 2295 O
CBC 151 154 2296 2299 B-treatment
with 155 159 2300 2304 I-treatment
differential 160 172 2305 2317 I-treatment
, 172 173 2317 2318 O
urinalysis 174 184 2319 2329 B-treatment
, 184 185 2329 2330 O
basic 186 191 2331 2336 O
metabolic 192 201 2337 2346 O
panel 202 207 2347 2352 O
and 208 211 2353 2356 O
medical 212 219 2357 2364 O
history 220 227 2365 2372 O
) 227 228 2372 2373 O

Subject 0 7 2374 2381 O
reports 8 15 2382 2389 O
a 16 17 2390 2391 O
regular 18 25 2392 2399 O
xanthine 26 34 2400 2408 B-clinical_variable
consumption 35 46 2409 2420 I-clinical_variable
of 47 49 2421 2423 O
> 50 51 2424 2425 O
5 52 53 2426 2427 B-lower_bound
cups 54 58 2428 2432 I-lower_bound
of 59 61 2433 2435 O
coffee 62 68 2436 2442 O
or 69 71 2443 2445 O
black 72 77 2446 2451 O
tea 78 81 2452 2455 O
per 82 85 2456 2459 O
day 86 89 2460 2463 O
( 90 91 2464 2465 O
or 91 93 2465 2467 O
equivalent 94 104 2468 2478 O
xanthine 105 113 2479 2487 O
consumption 114 125 2488 2499 O
per 126 129 2500 2503 O
day 130 133 2504 2507 O
using 134 139 2508 2513 O
other 140 145 2514 2519 O
products 146 154 2520 2528 O
) 154 155 2528 2529 O

Subjects 0 8 2530 2538 O
who 9 12 2539 2542 O
have 13 17 2543 2547 O
donated 18 25 2548 2555 O
14.85 26 31 2556 2561 B-lower_bound
ounces 32 38 2562 2568 I-lower_bound
( 39 40 2569 2570 I-lower_bound
450 40 43 2570 2573 I-lower_bound
mL 44 46 2574 2576 I-lower_bound
) 46 47 2576 2577 I-lower_bound
blood 48 53 2578 2583 I-lower_bound
or 54 56 2584 2586 O
more 57 61 2587 2591 O
within 62 68 2592 2598 O
the 69 72 2599 2602 O
previous 73 81 2603 2611 B-upper_bound
8 82 83 2612 2613 I-upper_bound
weeks 84 89 2614 2619 I-upper_bound
prior 90 95 2620 2625 I-upper_bound
to 96 98 2626 2628 O
study 99 104 2629 2634 O
administration 105 119 2635 2649 O

Use 0 3 2650 2653 O
of 4 6 2654 2656 O
any 7 10 2657 2660 O
prescription 11 23 2661 2673 O
, 23 24 2673 2674 O
over 25 29 2675 2679 O
- 29 30 2679 2680 O
the 30 33 2680 2683 O
- 33 34 2683 2684 O
counter 34 41 2684 2691 O
, 41 42 2691 2692 O
or 43 45 2693 2695 O
complementary 46 59 2696 2709 O
nasally 60 67 2710 2717 O
administered 68 80 2718 2730 O
products 81 89 2731 2739 O
within 90 96 2740 2746 O
30 97 99 2747 2749 B-upper_bound
days 100 104 2750 2754 I-upper_bound
prior 105 110 2755 2760 I-upper_bound
to 111 113 2761 2763 O
enrollment 114 124 2764 2774 O
and 125 128 2775 2778 O
for 129 132 2779 2782 O
the 133 136 2783 2786 O
duration 137 145 2787 2795 O
of 146 148 2796 2798 O
the 149 152 2799 2802 O
study 153 158 2803 2808 O
( 159 160 2809 2810 O
i.e. 160 164 2810 2814 O
, 164 165 2814 2815 O
corticosteroids 166 181 2816 2831 B-treatment
, 181 182 2831 2832 O
decongestants 183 196 2833 2846 B-treatment
, 196 197 2846 2847 O
antihistamines 198 212 2848 2862 B-treatment
, 212 213 2862 2863 O
saline 214 220 2864 2870 B-treatment
sprays 221 227 2871 2877 I-treatment
, 227 228 2877 2878 O
sinus 229 234 2879 2884 B-treatment
washes 235 241 2885 2891 I-treatment
) 241 242 2891 2892 O

Use 0 3 2893 2896 O
of 4 6 2897 2899 O
any 7 10 2900 2903 O
systemic 11 19 2904 2912 B-treatment
, 19 20 2912 2913 O
topical 21 28 2914 2921 B-treatment
, 28 29 2921 2922 O
inhaled 30 37 2923 2930 B-treatment
, 37 38 2930 2931 O
or 39 41 2932 2934 O
nasal 42 47 2935 2940 B-treatment
corticosteroid 48 62 2941 2955 I-treatment
within 63 69 2956 2962 O
30 70 72 2963 2965 B-upper_bound
days 73 77 2966 2970 I-upper_bound
prior 78 83 2971 2976 I-upper_bound
to 84 86 2977 2979 O
enrollment 87 97 2980 2990 O

Use 0 3 2991 2994 O
of 4 6 2995 2997 O
any 7 10 2998 3001 O
topically 11 20 3002 3011 B-treatment
applied 21 28 3012 3019 I-treatment
agents 29 35 3020 3026 I-treatment
to 36 38 3027 3029 O
the 39 42 3030 3033 O
nasal 43 48 3034 3039 O
mucosa 49 55 3040 3046 O
( 56 57 3047 3048 O
i.e. 57 61 3048 3052 O
, 61 62 3052 3053 O
antibacterial 63 76 3054 3067 B-treatment
creams 77 83 3068 3074 I-treatment
, 83 84 3074 3075 O
Vaseline 85 93 3076 3084 B-treatment
) 93 94 3084 3085 O
within 95 101 3086 3092 O
30 102 104 3093 3095 B-upper_bound
days 105 109 3096 3100 I-upper_bound
of 110 112 3101 3103 O
enrollment 113 123 3104 3114 O

aged 0 4 3115 3119 B-age
18 5 7 3120 3122 B-lower_bound
to 8 10 3123 3125 O
50 11 13 3126 3128 B-upper_bound
years 14 19 3129 3134 I-upper_bound
( 20 21 3135 3136 O
inclusive 21 30 3136 3145 O
) 30 31 3145 3146 O

chronic 0 7 3147 3154 B-chronic_disease
bronchitis 8 18 3155 3165 I-chronic_disease

common 0 6 3166 3172 B-chronic_disease
cold 7 11 3173 3177 I-chronic_disease

ear 0 3 3178 3181 B-chronic_disease
infections 4 14 3182 3192 I-chronic_disease

emphysema 0 9 3193 3202 B-chronic_disease

maximum 0 7 3203 3210 O
smoking 8 15 3211 3218 B-clinical_variable
history 16 23 3219 3226 I-clinical_variable
of 24 26 3227 3229 O
less 27 31 3230 3234 O
than 32 36 3235 3239 O
ten 37 40 3240 3243 B-upper_bound
- 40 41 3243 3244 I-upper_bound
pack 41 45 3244 3248 I-upper_bound
years 46 51 3249 3254 I-upper_bound
( 52 53 3255 3256 O
i.e. 53 57 3256 3260 O
the 58 61 3261 3264 O
equivalent 62 72 3265 3275 O
of 73 75 3276 3278 O
one 76 79 3279 3282 B-upper_bound
- 79 80 3282 3283 I-upper_bound
pack 80 84 3283 3287 I-upper_bound
per 85 88 3288 3291 I-upper_bound
day 89 92 3292 3295 I-upper_bound
for 93 96 3296 3299 O
ten 97 100 3300 3303 B-upper_bound
years 101 106 3304 3309 I-upper_bound
) 106 107 3309 3310 O

ntermittent 0 11 3311 3322 O
or 12 14 3323 3325 O
persistent 15 25 3326 3336 B-chronic_disease
asthma 26 32 3337 3343 I-chronic_disease

respiratory 0 11 3344 3355 B-chronic_disease
infection 12 21 3356 3365 I-chronic_disease

sinusitis 0 9 3366 3375 B-chronic_disease

